Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imfinzi (durvalumab)
Pharma
ASCO: AZ looks to bring immunotherapy to early stomach cancer
An event-free survival benefit suggests that Imfinzi could be the first immunotherapy for early-stage stomach cancer.
Angus Liu
Jun 1, 2025 8:00am
AZ's Imfinzi checks off a win in high-risk bladder cancer study
May 9, 2025 10:14am
AZ's Imfinzi wins perioperative FDA nod in bladder cancer
Mar 31, 2025 12:34pm
AstraZeneca says Imfinzi keeps stomach cancer from coming back
Mar 7, 2025 9:48am
BMS's Opdivo scores overall survival triumph in NSCLC trial
Feb 19, 2025 10:06am
AstraZeneca logs China sales decline in Q4 amid probes
Feb 6, 2025 10:31am
